Investors

• President's Message
• Financial Results
• Investor Events
• Integrated Report
• Corporate Strategy
• ESG

• Feb. 24, 2023 InfoNotice Regarding Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary) 
• Feb. 10, 2023 InfoThird Quarter Financial Results
• Feb. 10, 2023 InfoNotification for the Candidates for the Board of Directors 
• Jan. 20, 2023 Info(Change of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business 
• Jan. 18, 2023 InfoNotice Regarding the Status and Completion of Stock Repurchase 

View All

• Management Policies
  • President's Message
  • Corporate Philosophy
  • Corporate Strategy
  • Directors and Executive Officers
  • Articles of Incorporation and Share Handling Regulations
  • Disclosure Policy
  • Business Risks
  • Company Presentation PDF
• IR Library
  • Financial Results
  • Investor Events
  • Corporate Disclosure
  • Securities Report
  • Integrated Report
  • Olympus Medical Business
• Stock Information
  • Shareholders' Information
  • General Meeting of Shareholders
  • Shareholder Returns
  • Corporate Bonds and Ratings
  • Analyst Coverage
• Financial Data
  • Annual Data
  • Quarterly Data
  • Download Financial Data
• ESG
  • Olympus Group ESG
  • Environment
  • Social
  • Governance
• About Us
  • Olympus’ Value Creation Model
  • Fact Sheet
  • About Olympus

Annual Schedule

* The schedule may be subject to change.

• Internet IR Commendation Award 2022 by Daiwa Investor Relations Co. Ltd.
• AAA Website, All Japanese Listed Companies' Website Ranking 2022, Overall and Sector by Nikko Investor Relations Co.,Ltd.